A sample report on
Japan Radiotherapy Market Analysis
This report presents a strategic analysis of the Japan Radiotherapy Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Japan Radiotherapy Market, and offers unmatched value, accuracy, and expert insights.
Report Scope
Report Attribute
Details
Number of Pages
70-80
Base Year for Estimation
2022
Forecast Period
2023-2030
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Research Approach
Secondary Research (80%), Primary Research (20%) Click on the icon to know the detailed methodology A Sample Report on Japan Radiotherapy Market Analysis I Confidential 3
Table of Content
CONTENT
PG. NO.
1. Market Overview
09-17
1.1. Market Overview: Global
1.2. Overview: Japan
1.3. Economic Overview: Japan
1.4. Statistics at a Glance: Japan
1.5. Digital Health in Japan
1.6. Healthcare Scenario in Japan
1.7. Health Insurance Coverage: Japan
2. Market Size and Forecasting
18-23
2.1. Market Size and Forecasts
2.2. Market Segmentation
2.2.1. By Technology
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 4
Table of Content
CONTENT
PG. NO.
2.2.2. By Application
2.2.3. By End User
3. Market Dynamics
24-28
3.1. Market Growth Drivers
3.1.1. Japan Radiotherapy Market Driver 1
3.1.2. Japan Radiotherapy Market Driver 2
3.1.3. Japan Radiotherapy Market Driver 3
3.2. Market Restraints
3.2.1. Japan Radiotherapy Market Restraint 1
3.2.2. Japan Radiotherapy Market Restraint 2
3.2.3. Japan Radiotherapy Market Restraint 3
4. Competitive Landscape
29-36
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 5
Table of Content
CONTENT
PG. NO.
4.1. Key Company Profile
4.1.1. Hitachi Ltd.
4.1.2. Toshiba Corporation
4.1.3. Mitsubishi Electric Corporation
4.1.4. IHI Corporation
4.1.5. Sumitomo Heavy Industries Ltd.
4.1.6. Shimadzu Corporation
4.1.7. Elekta K.K.
4.1.8. Hamamatsu Photonics K.K.
4.1.9. Osaka Heavy Ion Therapy Center
4.1.10. Varian Medical Systems
5. Regulatory & Reimbursement Scenario
37-40
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 6
Table of Content
CONTENT
PG. NO.
5.1. Regulatory Scenario
5.2. Reimbursement Regulation
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 7
Radiotherapy
▪ Radiotherapy, also known as radiation therapy, is a medical treatment that uses high doses of radiation to target and kill cancer cells. It is a crucial component in the management of various cancers and is employed with the goal of either curing the cancer, controlling its growth, or relieving symptoms
▪ Radiotherapy works by damaging the DNA inside the targeted cells, preventing them from dividing and, ultimately, leading to their destruction
There are two primary types of radiotherapy: external beam and internal (brachytherapy)
▪
External Beam Radiotherapy: This is the more common form of radiotherapy. It involves directing a focused beam of radiation from outside the body onto the cancerous cells. The patient typically receives treatment on an outpatient basis, and the sessions are carefully planned to maximize the radiation's impact on the cancer while minimizing exposure to surrounding healthy tissues
▪
Internal Radiation Therapy: In this type of radiotherapy, radioactive sources are placed directly inside or very close to the tumor. This allows for a highly targeted dose of radiation to be delivered to the cancer cells while reducing exposure to nearby normal tissues. This therapy is commonly used in the treatment of prostate, breast, and gynecological cancers
Japan Radiotherapy Market Analysis 1. Market Overview
1.1 Market Overview: Global Scenario of Radiotherapy
▪
Please be aware that this sample report is
50%
<60%
intended to provide you with a brief
of all patients with cancer
patients have access to
overview of the kind of information and
worldwide require
radiotherapy in middle income
analysis that will be presented in the final
radiotherapy
countries
report
▪
In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
10 Mn+
0.4 Mn
application of medical devices, new
Deaths due to cancer, 1/3rd of
Children develop cancer
technology, and other details related to the
which is due to tobacco
each year
topic
consumption
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
43.1%
$6.9 Bn
▪
Final report will be comprehensive and
Is the market share of North
is the estimated global
detailed, and it will include data, analysis,
America in the world
market for radiotherapy
trends, and other relevant information
for 2022
related to the topic or subject matter of
interest
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 10
1.1 Market Overview: Global
Europe
~Revenue to reach
$3.2 Bn by 2030
North America
~Market Size of
$3.6 Bn
APAC
-Fastest CAGR
Africa
~Market Size of
Japan
$xx Bn
~Market Size of
$xx Bn
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 11
1.2 Overview: Japan
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will get an
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
125 Mn +
4.2 Tn
and other details related to the topic
Population of Japan
Is the Gross Domestic
in 2022
Product (GDP) in
▪
In order to obtain access to all of the
Japan in 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
49.1
11.5%
detailed, and it will include data, analysis,
Is the median age
of Japan’s GDP is spent
trends, and other relevant information
in Japan, in 2022
on health in 2022
related to the topic or subject matter of
interest
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 12
1.3 Economic Overview: Japan
Population of Japan, (2020-2030)
GDP of Japan, (2020-2030)
XX
XX
XX
XX
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population Split (2023)
▪
In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, By Gender
By Age Group
healthcare expenditure and other details related to the topic
▪
In order to obtain access to all of the information that you are 0-14
seeking, you will need to purchase the final report 15-24
Female
Male
▪
Final report will be comprehensive and detailed, and it will 25-54
51%
49%
include data, analysis, trends, and other relevant information 55-64
related to the topic or subject matter of interest 65+
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 13
1.4 Statistics at a Glance: Japan
Japan Radiotherapy Market Statistics
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
283,000
1 Mn+
final report
number of patients who
newly diagnosed patients with
received radiotherapy in
cancer in the country per year
▪
In this section you will get an
2019
understanding of the topic, which
includes the prevalence of the disease,
the application of medical devices, new
technology, and other details related to
the topic in Japan
▪
In order to obtain access to all of the
50%-60%
<30%
information that you are seeking, you
of patients with cancer
of patients with cancer had
will need to purchase the final report
needed radiotherapy as part
access to radiotherapy in Japan
of their cancer treatment
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 14
1.5 Digital Health in Japan
Japan Digital Health Market Forecast, 2022-2030 (in $Bn) 2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In this section you will get an understanding of the overall Digital Health market in Japan, which includes the market size, current trends and other details related to the topic
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 15
1.6 Healthcare Scenario in Japan
Healthcare scenario in Japan is characterized by a robust system that provides universal access to high-quality healthcare services
Public Health Insurance
Private Health Insurance
▪ National Health Insurance (NHI): Every Japanese citizen and resident
▪ Around X% of the total population in Japan (except short-term residents) can subscribe to NHI
▪ Public health insurance covers most citizens/residents and the system
▪
pays 70% or more of medical and prescription drug costs with the Pricing is
remainder being covered by the patient
Cost of Healthcare System in Japan
▪
Japan public healthcare is funded by the
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 16
1.7 Health Insurance Coverage: Japan
% of People by Type of Health Insurance Coverage Number of People By Health Insurance Coverage (2022)
Coverage Type
2020
2021
Change %
Uninsured
8.3
Total
327,521
328,074
With health insurance
91.7
Any health plan
299,230
300,887
0.4
Any private plan
217,896
216,366
–0.6
Any private plan
66.0
Employment-based
178,737
178,285
–0.2
Employment-based
54.3
Direct-purchase
10.2
Direct-purchase
33,869
33,555
–0.1
Marketplace
3.5
Marketplace coverage
10,924
11,389
0.1
TRICARE
2.5
TRICARE
9,165
8,299
–0.3
Any public plan
112,925
117,095
1.2
Any public plan
35.7
58,541
60,226
0.5
Medicare
18.4
58,778
61,940
0.9
Medicaid
18.9
VA and CHAMPVA
2,967
3,151
0.1
VA and CHAMPVA
1.0
Uninsured
28,291
27,187
–0.4
▪
In 2022, most people (98.3%) had health insurance coverage at some point during 2022 and 1.7 % of people were uninsured for the entire calendar year
▪
More people had private health insurance (66%) than public coverage (35.7%)
▪
Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 17
Japan Radiotherapy Market Analysis 2. Market Size and Forecasting
2.1 Market Size and Forecasts
Japan Radiotherapy Market Forecast,
2022-2030 (in $Bn)
Click on the icon to know the
methodology and assumption
XX
XX
▪
Please be aware that this sample report is
intended to provide you with a brief overview
of the kind of information and analysis that
will be presented in the final report
▪
In this section you will get an understanding
of the overall market, which includes the
market size, current trends and other details
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
related to the topic
2023
2024
2025
2026
2027
2028
2029
2030
▪
In order to obtain access to all of the
information that you are seeking, you will
Major Markets Patient
2.74
2.82
2.90
2.94
2.98
3.02
3.07
3.12
need to purchase the final report
($Mn)
▪
Final report will be comprehensive and
Japan Patient Size ($Bn)
0.51
0.61
0.68
0.69
0.70
0.71
0.72
0.73
detailed, and it will include data, analysis,
trends, and other relevant information related
% of Patients
18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
to the topic or subject matter of interest
Global Market Size ($Bn)
3,620
3,780
3,950
4,128
4,314
4,508
4,711
4,937
Japan Market Size ($Bn)
61
74
84
87
91
95
99
106
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 19
2.2 Snapshot of Radiotherapy Market Segmentation By Technology
By Application
By End User
External Beam Radiation Therapy
Lung Cancer
Hospitals
Internal Beam Radiation Therapy
Prostate
Radiotherapy Centers
Others
Colon
Research Institutes
Breast
Others
▪
In this section you will get an understanding of the segmentations which will cover the Japan Radiotherapy Market
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 20
2.2.1 Market Segmentation: By Technology
▪
External Beam Radiation Therapy in
Japan Radiotherapy Market Share,
Japan is a significant component of the
By Technology (2022)
overall Market
▪
Please be aware that this sample report
is intended to provide you with a brief
Others
overview of the kind of information and
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
External Beam
information that you are seeking, you
Radiation
will need to purchase the final report
Therapy
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic
Internal Beam
Radiation
Therapy
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 21
2.2.2 Market Segmentation: By Application
▪
Lung Cancer applications dominate the
Japan Radiotherapy Market Share,
market compared to other segments
By Application (2022)
with a substantial xx%
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Others
Lung Cancer
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic
Prostate Cancer
Breast
Cancer
Colon Cancer
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 22
2.2.3 Market Segmentation: By End User
▪
Hospitals in Japan are a significant
Japan Radiotherapy Market Share,
contributor to the overall Market
By End User (2022)
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Research
Institutes
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
Hospitals
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic
Radiotherapy
Centers
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 23
Japan Radiotherapy Market Analysis 3. Market Dynamics
3.1 Market Growth Drivers
3.1.1 By 2050, cancer prevalence in Japan is projected to reach 3,665,900 (3,210,200 to 4,201,400) thousand cases, representing a 13.1% increase from 2020
▪
Shifts in dietary patterns, alterations in cigarette Prevalence of various Cancers
consumption, changes in the age of marriage, variations in the number of births, and advancements in cancer Brain, central…
screening, diagnosis, and treatment collectively account for Gallbladder
the observed changes in cancer prevalence
Ovary
Lip, oral cavity
▪
Please be aware that this sample report is intended to Cervix uteri
provide you with a brief overview of the kind of information Leukaemia
and analysis that will be presented in the final report Corpus uteri
Thyroid
▪
In order to obtain access to all of the information that you are Kidney
seeking, you will need to purchase the final report Oesophagus
Non-Hodgkin…
▪
Final report will be comprehensive and detailed, and it will Bladder
include data, analysis, trends, and other relevant information Pancreas
related to the topic or subject matter of interest Liver
Rectum
Breast
Colon
Prostate
Stomach
Lung
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 25
3.1 Market Growth Drivers (continued)
3.1.2 Continuous advancements in radiotherapy technologies, coupled with substantial capital investment
▪
Ranked as the 3rd largest market globally for radiation Top Technology & Investment
oncology, Japan is home to the National Cancer Center Hospital, a prominent national cancer treatment facility with a rich history of delivering patient care for over six decades Type
Investment
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information XX
30.1%
and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report YY
23.4%
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ZZ
13.5%
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 26
3.1 Market Growth Drivers (continued)
3.1.3 Collaborative efforts between public and private entities, combined with substantial funding for clinical trials
▪
Organizations such as the National Institutes for Quantum and Clinical Trials Participation in Japan
Radiological Science and Technology (QST) and the National Institute of Radiological Sciences (NIRS) have played a pivotal role in advancing heavy ion radiotherapy using carbon ions.
▪
such collaborative approach not only facilitates crucial clinical trials but also accelerates the development and adoption of novel radiotherapy techniques, positioning Japan as a leader in cancer diagnosis and treatment
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 27
3.2 Market Restraints
3.2.1 Limited Access to Advanced
3.2.2 Workforce Shortages and
3.2.3 Regulatory Challenges and
Radiotherapy Technologies
Training Gaps
Compliance Burdens
▪
Access to advanced
▪
A shortage of skilled
▪
Stringent regulations may pose
radiotherapy technologies may
professionals in the field of
challenges for market players in
be constrained by factors such
radiotherapy, including
terms of product approvals,
as high initial costs, limited
oncologists and radiography
certifications, and adherence to
infrastructure, and regional
professionals, poses a significant
evolving standards, potentially
disparities in healthcare
restraint. The demand for
slowing down the introduction of
resources
radiotherapy services may
new technologies and treatments
outpace the availability of trained
▪
This limitation can impede the
personnel, leading to challenges
▪
In order to obtain access to all of
widespread adoption of cutting-
in delivering timely and quality
the information that you are
edge radiotherapy modalities,
treatments
seeking, you will need to
restricting patient access to the
purchase the final report
latest and most effective
▪
In order to obtain access to all of
treatments
the information that you are
▪
Final report will be
seeking, you will need to
comprehensive and detailed, and
▪
In order to obtain access to all of
purchase the final report
it will include data, analysis,
the information that you are
trends, and other relevant
seeking, you will need to
information related to the topic or
purchase the final report
subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 28
Japan Radiotherapy Market Analysis 4. Competitive Landscape
4.1 Key Company Profile
Key Note:
▪
Here is the list of top 10 companies which
Shimadzu
will be covered in the final report
1
Hitachi Ltd.
6
Corporation
▪
Each company will have slides for
o Overview
o
2
Key details
Toshiba Corporation
7
Elekta K.K.
o Offerings
o Name of products
o Recent activities/ Press Coverage
Mitsubishi Electric
Hamamatsu
3
8
Corporation
Photonics K.K.
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
Osaka Heavy Ion
o Financials (As per availability)
4
IHI Corporation
9
Therapy Center
▪
If there are specific companies that you
would like to be included in the report, please let us know via email
Sumitomo Heavy
Varian Medical
▪
In order to obtain access to all of the
5
10
Industries Ltd.
Systems
information that you are seeking, you will
need to purchase the final report
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 30
4.1.1 Hitachi Ltd.
Founded: 1910
▪
Hitachi Ltd. is involved in healthcare through its innovative technologies and Global HQ: Tokyo, JP
systems/solutions. They deliver digital technology and innovation for Hitachi Ltd. specializes in a wide
implementing healthcare services tailored to individuals range of products and solutions,
Revenue: $ 60.53 Bn
▪
Hitachi's healthcare solutions include radiation therapy for improving the including digital systems, power
No. of Employees: 368,247
quality of life in cancer treatment and in-vitro diagnosis and renewable energy solutions,
Locations: 150+
▪
A significant portion of its revenue generated from international markets, railway systems, and healthcare
particularly Asia, Europe, and North America
products
Website: hitachi.com
Recent Activity/ Press Coverage
Key Financials
80. 0
36.2%
37. 0%
$72.1
▪
Oct, 2023: Hitachi Asia Ltd. has announced the successful delivery of a 70. 0
36. 0%
$61.6
$60.9
proton therapy system to the National Cancer Centre Singapore. This 60. 0
35. 0%
marks Hitachi's inaugural proton therapy system to commence operations 50. 0
34. 0%
in Southeast Asia
32.6%
40. 0
33. 0%
31.4%
30. 0
32. 0%
▪
May, 2022: Hitachi High-Tech Corporation, in a strategic move, has 20. 0
31. 0%
initiated a partnership with Invivoscribe, Inc., a leading global provider of blood cancer testing kits and services. The Partnership aims to accelerate 10. 0
$4.7
30. 0%
$0.9
$3.6
the molecular diagnostics and precision medicine businesses of both 0.0
29. 0%
companies
2020
2021
2022
Revenue ($ Bn)
Net Income ($ Bn)
Gross Profit margin
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 31
4.1.1 Hitachi Ltd. (continued)
Partnerships
tnerships Ecosy
Ecosystem
stem
Major Distribution Partners
GE Healthcare is a leading provider of medical imaging and information technology solutions
&partners with IBM Watson to offer AI-powered solutions for cancer diagnosis, and patient monitoring.
Philips Healthcare is a leading provider of healthcare technology solutions and partners with IBM
Watson to offer AI-powered solutions for patient engagement,and remote monitoring.
Siemens Healthineers is a leading provider of medical imaging and information technology solutions and partners with IBM Watson to offer AI-powered solutions for cancer diagnosis, treatmentplanning, and patient monitoring.
Cerner is a leading provider of electronic health records (EHR) and healthcare information technology solutions.
Epic Systems is a leading provider of EHR and healthcare information technology solutions.
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 32
4.1.1 Hitachi Ltd. (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 33
4.1.2 Company 2
Founded:
Global HQ:
Revenue:
No. of Employees:
Locations:
Website:
Recent Activity/ Press Coverage
Key Financials
120.0
56.1%
57. 0%
$104.8
56. 0%
100.0
$93.5
$96.7
53.2%
55. 0%
54. 0%
80. 0
53. 0%
52. 0%
60. 0
49.8%
51. 0%
50. 0%
40. 0
49. 0%
20. 0
$13.8
$19.1
$10.7
48. 0%
47. 0%
0.0
46. 0%
2020
2021
2022
Revenue ($ Bn)
Net Income ($ Bn)
Gross Profit margin
Sources:
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 34
4.1.2 Company 2 (continued)
Partnerships Ecosystem
Major Distribution Partners
Major Vendor Partners
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 35
4.1.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
xx
xx
xx
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 36
Japan Radiotherapy Market Analysis 5. Regulatory & Reimbursement Scenario
5.1 Regulatory Scenario
Pharmaceuticals and Medical Devices Agency (PMDA)
▪
The PMDA is a regulatory agency responsible for ensuring the safety, efficacy, and quality of pharmaceuticals and medical devices in Japan
▪
It reviews and approves applications for marketing authorization, including those related to radiotherapy equipment, ensuring compliance with Japanese regulatory standards Ministry of Health, Labour and Welfare (MHLW)
▪
The MHLW oversees health-related policies in Japan and plays a crucial role in the regulation and supervision of medical devices, including radiotherapy equipment
▪
It works in conjunction with the PMDA to establish and enforce regulatory standards, guidelines, and protocols for the safe and effective use of radiotherapy technologies Ill
Il ust
lus r
t ativ
ati e
v
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 38
5.2 Reimbursement Regulation
Government provide health insurance
In Japan, the reimbursement and regulation of radiotherapy involve a combination coverage for more than 4 in 10
of public and private entities.
Population
Public Insurance :
o Public reimbursement for healthcare services in Japan is primarily Other Public
managed through the national health insurance system, overseen by 1%
the Ministry of Health, Labour and Welfare (MHLW).
Other Private
o The government determines reimbursement rates within this universal 3%
Uninsured
9%
healthcare framework. The national health insurance system ensures broad access to medical treatments, including radiotherapy, and the MHLW plays a central role in establishing reimbursement policies and Public
Insurance
rates
38%
Private Insurance:
o Private reimbursement for healthcare services in Japan involves collaboration between private insurance companies and healthcare providers. Insurance companies negotiate and determine reimbursement rates for services covered under private insurance Employer-Sponsored
49%
plans
o Private healthcare providers, such as hospitals and clinics, play a crucial role
Health Insurance Coverage, 2022
Ill
Il ust
lus r
t ativ
ati e
v
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 39
5.2 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population)
Source of Funding
Spend on Healthcare (%of Current Health Expenditure) Government Expenditure
Public Healthcare
Private Health Insurance
Coverage
Out of Pocket
Private Coverage
Other
NA
NA
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Public healthcare coverage is provided by the government and includes programs like Public and Private
6.3%
4.08%
5.1%
3.8%
2.2%
2.4%
3.6%
GDP Growth (yoy)
Public is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 14.7%
11.3%
15.5%
7.5%
4.2%
NA
NA
HC Spend Growth (yoy)
Private is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources Reimbursement Market Trends
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative
A Sample Report on Japan Radiotherapy Market Analysis I Confidential 40
A division of
Life-sciences Market Research
Reports you can trust
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level
perspective. Our services also include the provision of customized research reports, meticulously
tailored to align with your specific requirements.
Pharma
Digital
(Diseases
Health
& Drugs)
Market Research
Reports across various
OTC &
Medical
Nutraceuticals
Devices
categories in healthcare
At Insights10, our extensive report
library spans a diverse range of
Clinical
Healthcare
Trials
Services
categories within the field of life
sciences.
Rare
Diseases
Global Coverage
• India
• China
• Japan
• Poland
• Austria
• Ireland
• Malaysia
• Norway
• Thailand
• Denmark
• Vietnam
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
Click on the country to see the reports available
What do our reports cover?
1
Market Overview
6
Competitive Landscape
2
Growth Drivers & Growth Restraints
7
Policy & Regulatory Landscape
3
Epidemiology & Disease type
8
Reimbursement Scenario
4
Market Size & Forecast
9
Recent Developments
5
Market Segmentation
10
Factors Driving Future Growth
Our Research Process
01
02
03
04
05
06
Define
Gather data
Validate data
Forecast
Extract key
Compile &
precise
through
through primary
market size
insights from
present a
research
secondary
research
and segment
the research
comprehensive
questions
research
interviews
analysis
findings
analytical report
Data Triangulation & Data Validation
Top Down Approach
Find
Examine the total healthcare expenditure in
final
the targeted disease or service domain.
market size
Assess the proportion of spending
allocated to the specific product or
Predict future market
treatment category.
growth or decline based
on key market trends &
Predict future market
dynamics
growth or decline
based on key market
Analyze product or treatment pricing
trends & dynamics
and reimbursement strategies
Find
Evaluate consumer or patient
final
demographics and numbers
market
size
Bottom Up Approach
Report Scope
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Pricing and Purchase
Our pricing and purchase options are adaptable to Base
2022
suit the specific scope of work.
Year for
estimation
Typically, the delivery of the final report falls within a Delivery Timeline
timeframe of 5 to 7 business days, but the exact 2023-Forecast
duration may vary depending on the project's scope.
2030
Period
We are pleased to offer you the option of
Customization
customizing the report to align with your specific research requirements at no extra charge, provided it falls within the defined scope of the project.
Statistical
Databases
Access to credible
Press
Annual
Releases
Reports
data sources for
secondary research
We have access to a multitude of highly
dependable data sources, supported by
White-
Trade
papers
Publications
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Published
Online
Research
Databases
Reports
Our reports present data, which is
Reliable
The report is prepared using a proven methodology and insightful research
Expert Verified
The report is prepared by a team of highly qualified & experienced research analysts & vetted by our local associates Realistic
The report allows you to confidently make smarter business and strategic decisions based on realistic findings Comprehensive
Covers everything you would need to know about the market including market size, competitive analysis & much more Easy to read
You do not have to be a market expert to understand what really is happening on the market and how it works
Our Services
Syndicated Market
Customized Market
Primary Research &
Research Reports
Research Reports
Interviews
Database Service
Full-Time
Conference
& KOL Mapping
Engagement
Coverage
Competitive
Regulatory
Yearly Access
Intelligence
Compliance
(Subscription)
CEO Speaks
“The business decision-making process is no longer as straightforward as it used to be. It requires insights generated at the right time, based on reliable data interpreted in a nuanced manner for each market. We at Insights10 are building the future of market research and are committed to providing our clients with the right intelligence and insights to make business decisions quickly and efficiently.
Insights10 is a unique platform that combines deep domain expertise, nuanced data at a country and functional area level, and years of experience working with some of the best organizations in the world, generating insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
Leadership Team
Dr. Purav Gandhi
Anish Swaminathan
Mukesh Nayak
Ritu Baliya
Founder & CEO
Director
Head – Marketing & Research
Engagement Manager
Purav is a physician and an
Anish has 15+ years of
Mukesh is an engineering graduate with
Ritu has over 6 years of experience in
entrepreneur with 12+ years of
experience in management
an MBA in Marketing. He is a seasoned
strategy building, market assessments,
experience in Healthcare & Life
consulting in the Life Sciences
healthcare market research &
market sizing, and RWE for global MNC
Sciences industry spanning across
sector, and has worked with
marketing professional with a
healthcare & biopharma clients across
strategy, market access, health
diverse multinational firms in
progressive experience of over 20
diff. markets (America, Europe, Africa,
informatics and RWE, digital health,
the US, India, Middle East and
years in Life Sciences, Healthcare
APAC and Middle East). Her areas of
analytics and data science. Purav
APAC regions. His primary area
services, Pharma and Medical Device
expertise include: Indentifying emerging
studied medicine from Gujarat
of interest is Customer and
sectors. With an in-depth understanding
trends in life sciences industry,
University and also completed his MBA
Market Strategy, Market
of primary research, he has conducted
Competitor landscape assessment,
from IIM-Kozhikode. Purav started his
Access, and Digital Health with
hundreds of interviews of various
Disease opportunity assessments etc.
career with Deloitte working on strategy
special focus on emerging
stakeholders in pharma & healthcare &
She is a pro in secondary and primary
consulting engagements and also co-
markets like Africa, Middle East
completed several research projects
research with a deep domain expertise
founded ConvergeHealth by Deloitte.
and APAC.
across life sciences industry.
in healthcare sector.
@Our Team
@Work
Beyond Work
Our Clients
Pi-SM
GmbH
… and many more
What our clients say
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA) I've had the pleasure of availing Insights10’s services several times, and I've always been impressed by their expertise, professionalism, and dedication to providing us with the highest quality data and insights. Whether one is looking to launch a new product, expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use their knowledge to develop customized research solutions that meet the specific needs of each client. I highly recommend Insights10 to anyone looking for a reliable and experienced partner in healthcare market research. They're a valuable asset to any company that wants to succeed in this dynamic sector.
What our clients say
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
Dear Insights10 Team, I wanted to thank you all for the great work you conducted producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The quality of the report was excellent, and you managed to complete it in record time. I was also impressed by your quick turnaround on the topics discussed as a follow up after the report's first version; you managed to gather the information required, plus a very good analysis.
I will definitely consider working with you again if the opportunity arises, and will not hesitate in recommending you to colleagues working in the field Thank you again for your professionalism and team work. It was a pleasure working with you.
What our clients say
Michael Blumberg
Youssef Mallat
Co Founder GFAU Pty Ltd., Australia
Opusline, A part of Accenture, Paris
Co Founder – Embi, Optimum Oral care, Australia We engaged INSIGHTS10 to assist us with our research requirements The info you delivered on the European Patient
for the Oral Care Market sector in Australia. We been very impressed Support Market with a deep dive into countries
with the depth and quality of data and equally with the personal like Spain, Germany, Italy, France, UK and
service we experience from the management team on our account.
Belgium, was very useful.
They understand our business, our challenges and our goals. There is a real sense of partnership as we continue to work together.
Wissem Menad
Senior Manager Segment Marketing
Performance Health, London, UK
Dr. Robert Ryan
Insights10 has been a great resource for
Chief Executive Officer, Innova Therapeutics, Inc., USA getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
We were looking for very specific information regarding Abu Dhabi sources for getting global reports, but now I
Oncology Drugs Market. The insights provided by Insights10 is can get in-depth country reports from
fantastic and they just took less than three days to deliver the report.
Insights10 which has been a game changer.
Do you have
any questions?
We would be happy to help.
Thank You
Email: insights@insights10.com
India: (+91) 931 639 7935
